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A brief guide to the analysis, interpretation, and presentation of microbiota data 
 
Dr Stefan Zalewski, Dr Christopher J. Stewart, Dr Nicholas D. Embleton, Dr Janet E. Berrington 
Introduction to terminology and technologies 
There has been an increase in research using new ‘omic’ technologies (1) (those allowing the study 
of a large biological dataset)  designed to define and describe the microorganisms we carry, and 
their impact on health and disease. Omic technologies generate enormous quantities of complex 
data, so a major challenge is inter- and intra-study comparisons. This article provides an overview of 
terminology and data generation, and uses one of our study datasets to demonstrate different 
presentations of that data.  
Bacteria are important in a range of physiological processes in humans (2):  nutrient assimilation, 
vitamin production, modification of the nervous system (the gut-brain axis) and development of the 
immune system(3). Pathological changes in gut microbial communities (dysbiosis) have been 
associated with a wide range of diseases including skin and psychiatric disorders (4, 5), as well as 
diseases with high mortality in preterm infants such as infection and necrotising enterocolitis (NEC). 
NEC, for example, has been associated with reduced microbial diversity and increase in specific 
classes of bacteria, such as Gammaproteobacteria (6-8). 
Identified by culture, bacteria were traditionally classified by physical characteristics into taxonomic 
ranks - phylum, class, order, family, genus and species. Sequencing based technologies rely on 
similarity in DNA sequences to determine organisms’ phylogenetic relatedness to other species.  
DNA Sequencing is a method for assessing microbial communities which works, either through 
identification of all genomes within a community (metagenomics), or using specific markers genes 
such as the 16S rRNA gene (9). The bacterial 16S rRNA gene can be used to group sequences by 
percentage similarity to each other, typically ‘binning’ (collecting together) all sequences with more 
than 97% similarity as a single operational taxonomic unit (OTU), which is then cross-referenced with 
databases to identify bacterial genus (or higher taxonomic levels if genus unavailable). The relatively 
short read length of 16S rRNA gene sequencing and homologous sequences between different 
genera prevent classification of OTUs to the species level. The cultivable fractions of clinical samples 
can be identified to species level by Sanger sequencing using the full length 16S rRNA gene. Isolates 
and clinical samples with single bacteria (e.g. blood infections) can also be sequenced by Sanger 
sequencing with amplicons as small as 320bps(10). The most comprehensive means of determining 
species level identification in complex clinical samples (e.g., stool) use metagenomic sequencing to 
computationally map random regions (i.e., not specific to the 16S rRNA gene) of DNA to known 
species. 
 Sequencing methods allow high-throughput untargeted detection of the microbial community(11) 
but data can be biased by methods of DNA extraction, primer selection in Polymerase chain reaction 
(PCR), sequencing technology, and bioinformatic processing (E.g. there are frequent annotation 
errors within sequencing databases such as BLAST(12)). Interpretation is further challenged when 
studies present results at different taxonomic levels (e.g. genus vs. phyla). Aggregation by species 
can miss differences in strains which could have functional importance. Associations of the relative 
abundance (%) of organisms also discount potentially discordant functional impacts of low abundant 
organisms and do not account for differences in absolute load.  
 
 
Analysis and presentation of OTU data 
Different numeric descriptive measures and graphical techniques can be used to illustrate key 
features of the microbiota that may be relevant to disease development as depicted below.  We 
present an example of typical microbiome analyses using existing data (13-15) to show how different 
representations may affect interpretation. Details of the cohort are described previous work (13-15). 
Briefly, the dataset comprises 776 stool samples collected from 46 exclusively preterm infants (<32 
weeks gestation). Of the 776 samples, 56 samples from 3 patients never received any expressed 
breast milk (EBM). 
Numeric descriptors: 
Diversity: Diversity relates to the number of different OTUs and their relative abundance, and is 
often a primary outcome in microbiome studies, although variably presented. Higher diversity is 
often associated with better health outcomes but not always (16). The number of distinct OTUs 
corresponds to richness and the relative abundance reads for each OTU allows a measure of 
diversity. Diversity is dictated by richness and evenness, where evenness considers if a single OTU 
dominates the sample (lower diversity) or no OTU is dominant (higher diversity). For example, two 
communities that contain only taxa A and B, one with 9 OTUs of taxa A and 1 of taxa B and the other 
with 5 of each, both have equal richness but the latter is more even. Diversity indices offer a 
combination measure of richness and evenness. The most commonly reported in neonatal studies is 
the Shannon diversity index (H) which describes the relative uncertainty of correctly predicting the 
next taxa, such that where one OTU dominates H approaches zero (reflecting low diversity), even if 
multiple other rare taxa are present. Shannon diversity typically ranges from 0 to 2 in neonatal 
studies (7, 17). Alpha diversity describes diversity in one site or sample i.e the total number of 
different OTUs and how abundant each of them are in relation to one another within one sample 
(Figure 1A and 1B).  Beta diversity is a measure of how different sites or samples are (in terms of 
OTUs composition) compared to each other (Figure 1C) (18).  
Graphical techniques: 
Ordination 
Ordination, for instance principal coordinate analysis (PCoA), places samples in ordination space 
based on their total microbiota profiles. If all OTUs from all samples were shared evenly between 
samples, these samples would sit at ordinates 0,0. Thus samples further from this point are more 
different from ‘average’ than those near to this point, and samples placed closer together are more 
similar to each other than those further away from each other. This is used to compare samples with 
different variables of interest, (e.g. exposure or health outcome). Figure 1C demonstrates 
differences in stool microbiota between breast-fed and formula-fed infants. The data can be 
combined to produce centroids (hypothetical ‘average’ sample points) for each group. Ordination 
axes show proportion of total variability accounted for by the ordination space components, and 
thus residual unexplained differences. 
As well as studying the community as a whole, many studies seek to identify and compare specific 
taxa in association with health and disease states.  
Heat Maps 
Heat maps (Figure 1D) cluster samples and OTUs based on similarity within the dataset. Each column 
represents a different patient/sample with each row representing single taxa, allowing visualisation 
of samples that are similar in one or more key taxa, termed clusters, which can then be related to 
exposure or outcome variables of interest. Image 1D shows the 10 most abundant genera in this 
dataset.  
Stacked Bar Charts 
Stacked bar charts show relative abundance of each taxa within a sample, and can be drawn at 
different taxonomic levels. They can identify change in relative abundance over time within an 
individual or between groups. In samples with high diversity, the charts often show family or order 
taxonomic level (anything lower is visually uninterpretable). Fig 1E shows our data at order and 1F at 
genus level for comparison.  As shown, the data can be presented split by intervention or outcome 
measure to aid interpretation. 
Associating patient data and taxonomic data 
Ultimately analysis will seek to associate variables of clinical relevance, such as the development or 
protection from disease, with changes in bacterial taxa. Because many OTUs are detected, and thus 
many comparisons will be made for each OTU and each clinical variable, Statistics must be applied 
cautiously and it is important to adjust P values for multiple comparisons. For instance, if comparing 
100 OTUs and using a P value <0.05 to define significance, simply by chance 5 OTUs will be reported 
as significant. Likewise, if analysing multiple samples from the same person then the statistics should 
account for repeated measures to avoid inflation of P values. Despite these statistical difficulties, 
appropriately analyses datasets can point to changes in key OTUs associated with disease or 
treatments. 
Summary 
Paediatric research increasingly focuses on, or includes data from, microbial analysis, but 
presentation is highly variable and can be challenging for clinicians. Understanding the key 
descriptive terms and visual representation measures is important in data interpretation and any 
potential clinical inferences.  
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